Talk

Advanced search

A study looking at diagnosis and management of anaemia during pregnancy. Your thoughts about the study and relevant experiences would be helpful to improve the study

(1 Post)
Nitap Mon 30-Oct-17 16:33:14

BACKGROUND
Anaemia affects >50% of pregnant women worldwide. It causes several complications: premature births,smaller babies and maternal depression, shorter duration of breast feeding and blood transfusions, which carry risks of reactions, infections and development of antibodies.
Despite government initiatives to improve management of anaemia, there remains a significant delay before anaemic women are commenced on treatment. When anaemia is diagnosed in the community a pregnant woman attends clinic and has a blood test to check her haemoglobin. This sample is couriered to the hospital
laboratory; the midwife chases the result retrospectively and can take up to 24 hours. If anaemia is diagnosed, the midwife makes contact with the woman asking her to make a GP appointment so iron tablets can be collected. This process can take up to four weeks.
AIMS OF STUDY
We will introduce a test enabling the midwife to know the woman’s haemoglobin in the clinic. This would mean the midwife could give iron tablets at the immediate time anaemia is diagnosed. In this study, we will be using a once daily intermediate dose of iron tablets as there is evidence this will be better absorbed with fewer side-effects than taking iron tablets several times a day. The HemoCue® haemoglobin analyser is a point of care test which measures haemoglobin accurately. We propose by using the HemoCue® haemoglobin analyser and treating anaemic women immediately, haemoglobin levels can be improved.
This is a preliminary study to assess whether this method of testing and treatment is acceptable to women and midwives.
STUDY DESIGN
Women will be recruited from community and hospital-based clinics and allocated randomly to follow current standard practice in accordance with trust policies (control group), or, to have their haemoglobin levels checked using the HemoCue® haemoglobin analyser and any requisite treatment initiated (intervention group).
PATIENT AND PUBLIC INVOLVEMENT
Patients and members of the public will be in the trial steering committee and will meet regularly. Feedback from trial participants about their experience and suggestions for improvement for the larger study will be sought.

Join the discussion

Join the discussion

Registering is free, easy, and means you can join in the discussion, get discounts, win prizes and lots more.

Register now